Related Experiment Video
Updated: Jan 28, 2026

Transesophageal Atrial Burst Pacing for Atrial Fibrillation Induction in Rats
Published on: February 14, 2022
Genome-Wide Copy Number Variation Association Study of Atrial Fibrillation Related Thromboembolic Stroke
Chia-Shan Hsieh1,2, Pang-Shuo Huang3, Sheng-Nan Chang4
1Department of Life Science, Genome and Systems Biology Degree Program, National Taiwan University, No. 1, Sec. 4, Roosevelt Rd., Taipei 106, Taiwan. cometrise@gmail.com.
Insights
Copy number variations (CNVs) are identified as genetic predictors for thromboembolic stroke risk in atrial fibrillation (AF) patients. These genetic factors may indicate an impaired alpha-adrenergic signaling pathway, offering new insights into AF-related stroke mechanisms.
Area of Science:
- Genetics
- Cardiology
- Genomics
Background:
- Atrial fibrillation (AF) is a prevalent cardiac arrhythmia and a primary cause of ischemic stroke.
- While clinical scores assess stroke risk, the role of genetic factors, including copy number variations (CNVs), in AF-related thromboembolism remains largely unexplored.
- Previous studies identified single-nucleotide polymorphisms associated with AF, but these do not account for all genetic predispositions.
Purpose of the Study:
- To identify specific CNVs that determine the risk of thromboembolic stroke in patients with atrial fibrillation.
- To investigate the potential genetic underpinnings of AF-related stroke beyond known clinical risk factors and single-nucleotide polymorphisms.
Main Methods:
- A genome-wide approach was employed, analyzing 109 AF patients with thromboembolic stroke against 14,666 controls from the Taiwanese Biobank.
- Statistical analysis identified chromosomal regions with significant deletions or amplifications associated with AF-related stroke.
- Pathway analysis was conducted on identified genes within these regions, focusing on affected signaling pathways.
Main Results:
- Significant deletions were found in chromosomal regions 1p36.32-1p36.33, 5p15.33, 8q24.3, and 19p13.3, and amplifications in 14q11.2, associated with AF-related stroke in the Taiwanese population.
- These regions encompass 148 genes, including microRNAs and long non-coding RNAs.
- Pathway analysis revealed deletions in genes like GNB1, PRKCZ, and GNG7, implicated in the alpha-adrenergic receptor signaling pathway, which is crucial for AF-related stroke risk.
Conclusions:
- Copy number variations (CNVs) represent potential genetic predictors for thromboembolic stroke risk in atrial fibrillation patients.
- The findings suggest a possible link between impaired alpha-adrenergic signaling and the mechanism of AF-related thromboembolism.
- Further research into CNVs and related pathways could enhance risk stratification and therapeutic strategies for AF patients.
Abstract:
Atrial fibrillation (AF) is a common cardiac arrhythmia and is one of the major causes of ischemic stroke. In addition to the clinical factors such as CHADS2 or CHADS2-VASC score, the impact of genetic factors on the risk of thromboembolic stroke in patients with AF has been largely unknown. Single-nucleotide polymorphisms in several genomic regions have been found to be associated with AF. However, these loci do not contribute to all the genetic risks of AF or AF related thromboembolic risks, suggesting that there are other genetic factors or variants not yet discovered. In the human genome, copy number variations (CNVs) could also contribute to disease susceptibility. In the present study, we sought to identify CNVs determining the AF-related thromboembolic risk. Using a genome-wide approach in 109 patients with AF and thromboembolic stroke and 14,666 controls from the Taiwanese general population (Taiwan Biobank), we first identified deletions in chromosomal regions 1p36.32-1p36.33, 5p15.33, 8q24.3 and 19p13.3 and amplifications in 14q11.2 that were significantly associated with AF-related stroke in the Taiwanese population. In these regions, 148 genes were involved, including several microRNAs and long non-recoding RNAs. Using a pathway analysis, we found deletions in GNB1, PRKCZ, and GNG7 genes related to the alpha-adrenergic receptor signaling pathway that play a major role in determining the risk of an AF-related stroke. In conclusion, CNVs may be genetic predictors of a risk of a thromboembolic stroke for patients with AF, possibly pointing to an impaired alpha-adrenergic signaling pathway in the mechanism of AF-related thromboembolism.
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid Fibrils
Conservative Site-specific Recombination and Phase Variation
The recognition sites for Cre recombinase called LoxP...
What is Variation?
The range, standard deviation, standard error, and variance are the different measures of variation.
Range: The range is the difference between its maximum and...
Genomics

